Dr. Donghua He 何冬花
Chief Physician
Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of multiple myeloma, lymphoma, plasma cell disorders, and acute and chronic leukemia.
Dr. He holds a medical doctorate from Zhejiang University and serves as a master’s supervisor. With over 10 years of experience in hematology, Dr. He has led two National Natural Science Foundation projects and two Zhejiang Provincial Natural Science Foundation projects. Dr. He has published more than 10 SCI papers as first or corresponding author and received one Ministry of Education Science and Technology Progress Award.
Professional roles
- Member, Rare Plasma Cell Disease Collaboration Group, China Anti-Cancer Association
- Member, Youth Committee, Hematology Branch, Zhejiang Medical Association
- Member, Rare Disease Group, Hematologist Branch, Zhejiang Medical Doctor Association
Name order: in Chinese the family name comes first (He Donghua). Papers usually list the name as Donghua He or He D.
Selected publications
19 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Med, 2026 (senior author): Efficacy and Safety of Low-Frequency Daratumumab Regimen in Systemic Light-Chain Amyloidosis. PubMed 42415367
- Leuk Lymphoma, 2026 (senior author): MRD contamination in peripheral blood autologous stem cell grafts: implications for relapse and prognosis in multiple myeloma. PubMed 41342196
- Cancer Med, 2024 (senior author): Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents. PubMed 39031026
- Cancer Sci, 2024 (senior author): Outcomes of COVID-19 in multiple myeloma patients treated with daratumumab. PubMed 37884287
- J Mol Med (Berl), 2011 (first author): Small Rab GTPase Rab7b promotes megakaryocytic differentiation by enhancing IL-6 production and STAT3-GATA-1 association. PubMed 20953574
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion